|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Nabriva Therapeutics AG (NBRV) |
|
|
$0.39 0.00 (0.00%) as of 4:30 Wed 12/2
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
150,780,000 |
Market
Cap: |
59.38(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.3938 - $0.3938 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Nabriva Therapeutics is a holding company. Through its subsidiaries, Co. is a biopharmaceutical company engaged in the research, development and commercialization of anti-infective agents to treat serious infections. Co. has approval from the U.S. Food and Drug Administration for XENLETA for the treatment of adults with community-acquired bacterial pneumonia. XENLETA is an oral and intravenous treatment in the pleuromutilin class of antibiotics available for the systematic administration in humans. Co.'s CONTEPO is a potentially epoxide antibiotic for intravenous use in the U.S. for complicated urinary tract infections. Co. may develop XENLETA and CONTEPO for additional indications.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
51,839 |
Total Sell Value |
$0 |
$0 |
$0 |
$9,588 |
Total People Sold |
0 |
0 |
0 |
6 |
Total Sell Transactions |
0 |
0 |
0 |
6 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Gelone Steven P. |
President and COO |
|
2022-03-06 |
4 |
D |
$0.43 |
$38 |
D/D |
(89) |
362,211 |
|
- |
|
Gelone Steven P. |
President and COO |
|
2022-02-28 |
4 |
D |
$0.45 |
$27 |
D/D |
(61) |
362,300 |
|
- |
|
Schroeder Theodore R |
Chief Executive Officer |
|
2022-02-28 |
4 |
D |
$0.45 |
$56 |
D/D |
(125) |
314,223 |
|
- |
|
Gelone Steven P. |
President and COO |
|
2022-02-06 |
4 |
D |
$0.48 |
$51 |
D/D |
(106) |
362,361 |
|
- |
|
Schroeder Theodore R |
Chief Executive Officer |
|
2022-02-06 |
4 |
D |
$0.48 |
$126 |
D/D |
(263) |
314,348 |
|
- |
|
Gelone Steven P. |
President and COO |
|
2022-01-31 |
4 |
D |
$0.48 |
$35 |
D/D |
(73) |
362,467 |
|
- |
|
Schroeder Theodore R |
Chief Executive Officer |
|
2022-01-31 |
4 |
D |
$0.48 |
$60 |
D/D |
(125) |
314,611 |
|
- |
|
Gelone Steven P. |
President and COO |
|
2022-01-29 |
4 |
D |
$0.45 |
$1,567 |
D/D |
(3,483) |
362,540 |
|
- |
|
Schroeder Theodore R |
Chief Executive Officer |
|
2022-01-29 |
4 |
D |
$0.45 |
$4,845 |
D/D |
(10,766) |
314,736 |
|
- |
|
Schroeder Theodore R |
Chief Executive Officer |
|
2022-01-06 |
4 |
D |
$0.58 |
$157 |
D/D |
(270) |
325,502 |
|
- |
|
Gelone Steven P. |
President and COO |
|
2022-01-06 |
4 |
D |
$0.58 |
$64 |
D/D |
(110) |
366,023 |
|
- |
|
Schroeder Theodore R |
Chief Executive Officer |
|
2021-12-31 |
4 |
D |
$0.60 |
$64 |
D/D |
(107) |
325,772 |
|
- |
|
Gelone Steven P. |
President and COO |
|
2021-12-31 |
4 |
D |
$0.60 |
$38 |
D/D |
(63) |
366,133 |
|
- |
|
Schroeder Theodore R |
Chief Executive Officer |
|
2021-12-28 |
4 |
B |
$0.57 |
$57,320 |
D/D |
100,000 |
325,879 |
2.81 |
-100% |
|
Naftzger J. Christopher |
General Counsel and Corp Sec |
|
2021-12-27 |
4 |
B |
$0.59 |
$4,130 |
D/D |
7,000 |
7,000 |
2.66 |
-100% |
|
Gelone Steven P. |
President and COO |
|
2021-12-06 |
4 |
D |
$0.72 |
$66 |
D/D |
(92) |
366,196 |
|
- |
|
Schroeder Theodore R |
Chief Executive Officer |
|
2021-12-06 |
4 |
D |
$0.72 |
$162 |
D/D |
(225) |
225,879 |
|
- |
|
Schroeder Theodore R |
Chief Executive Officer |
|
2021-11-30 |
4 |
D |
$0.78 |
$83 |
D/D |
(107) |
226,104 |
|
- |
|
Gelone Steven P. |
President and COO |
|
2021-11-30 |
4 |
D |
$0.78 |
$49 |
D/D |
(63) |
366,288 |
|
- |
|
Schroeder Theodore R |
Chief Executive Officer |
|
2021-11-06 |
4 |
D |
$1.33 |
$299 |
D/D |
(225) |
226,211 |
|
- |
|
Gelone Steven P. |
President and COO |
|
2021-11-06 |
4 |
D |
$1.33 |
$122 |
D/D |
(92) |
366,351 |
|
- |
|
Schroeder Theodore R |
Chief Executive Officer |
|
2021-10-06 |
4 |
D |
$1.08 |
$243 |
D/D |
(225) |
226,543 |
|
- |
|
Gelone Steven P. |
President and COO |
|
2021-10-06 |
4 |
D |
$1.08 |
$99 |
D/D |
(92) |
366,506 |
|
- |
|
Schroeder Theodore R |
Chief Executive Officer |
|
2021-09-30 |
4 |
D |
$1.19 |
$127 |
D/D |
(107) |
226,768 |
|
- |
|
Gelone Steven P. |
President and COO |
|
2021-09-30 |
4 |
D |
$1.19 |
$75 |
D/D |
(63) |
366,598 |
|
- |
|
323 Records found
|
|
Page 3 of 13 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|